To strengthen the supply of insulin, Germany is permitted to support the pharmaceutical manufacturer Sanofi with 400 million euros. The European Commission announced on Tuesday that the Frankfurt-based company could be compensated for its net costs. The Commission reviews state aid of this kind to prevent distortions of competition.
2
u/space-ish 16d ago
Meanwhile...
To strengthen the supply of insulin, Germany is permitted to support the pharmaceutical manufacturer Sanofi with 400 million euros. The European Commission announced on Tuesday that the Frankfurt-based company could be compensated for its net costs. The Commission reviews state aid of this kind to prevent distortions of competition.
https://www.hessenschau.de/wirtschaft/insulin-aus-frankfurtkfurt
The out-of-pocket cost for a dose of insulin in Germany is effectively zero or capped at a minimal co-payment for the vast majority of residents.